IDL Biotech continues to expand in Africa. IDL Biotech has signed a distributor agreement with Res Health Consult Ltd covering Ghana. The agreement covers the sale of TUBEX® TF.
Since its launch in Africa, the company has focused on finding the right partners for distribution. The company has previously announced that agreements have been signed with distributors in Uganda, Zimbabwe, Kenya, Rwanda, South Sudan and Somalia.
Now the company has also signed a distribution agreement with Res Health Consult Ltd for distribution in Ghana. The agreement covers the sale of the company’s rapid test; TUBEX® TF for typhoid fever.
Read the full press release here (Swedish)